Locations:
SearchAdvertisement
SCAI document focuses on technical aspects of care where clear guidance had been lacking
High composite score in myectomy specimens signals worse prognosis
Few patients report left ventricular dysfunction or heart failure after one year
Avoidance of septal reduction therapy continues while LVEF dysfunction remains infrequent
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Phase 2 trial of zerlasiran yields first demonstration of longer effect with each dose of an siRNA
OPTION trial demonstrates significantly less bleeding risk with comparable efficacy
Aortic valve replacement is best option for lowering mortality in this high-risk population
Novel approach outperforms standard of care for post-PVI stenosis and occlusion
27th offering of this CME favorite to be held March 6-9 in Hollywood, Florida
A graphical recap of our recent data from some key cardiovascular areas
Advertisement
Advertisement